Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1743studies shown
Showing 445-456 of 1,743
Drug study icon
CompletedNCT05481736

COMP360 Psilocybin Therapy for Eating disorders

This study is completed in the United States, in the United Kingdom, and in Ireland. It is testing COMP360 Psilocybin Therapy for Eating disorders.

In United Kingdom
Eating disordersDrugA study involving a medication or substance.Over 18 Years
Countries
United States, United Kingdom, Ireland
Sponsor
COMPASS Pathways
Condition
Eating disorders
Drug study icon
CompletedNCT01244490

Extended-release Guanfacine Hydrochloride for ADHD

This study is completed in the United States, in France, in Canada, .... It is testing Extended-release Guanfacine Hydrochloride for ADHD.

In United Kingdom
ADHDDrugFrom 6 Years to 17 Years
Countries
United States, France, Canada, ...
Sponsor
Shire
Condition
ADHD
Drug study icon
TerminatedNCT00622245

Lu AA34893 for depression in bipolarity

This study was terminated in Australia, in France, in Canada, .... It is testing Lu AA34893 for depression in bipolarity.

In United Kingdom
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
Australia, France, Canada, ...
Sponsor
H. Lundbeck A/S
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2006-006540-54

Efficacy of agomelatine (25 to 50 mg/day) given orally on improvement of subjective sleep in patients with Major Depressive Disorder. A randomised, double-blind, flexible-dose international multice...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionDrug
Countries
France, United Kingdom
Sponsor
Institut de Recherches Internationales Servier
Condition
Depression
Drug study icon
CompletedEUCTR 2009-016713-20

Eficacia de agomelatina 25mg/día (con posibilidad de incremento a 50mg/día tras 8 semanas de tratamiento) por vía oral durante 16 semanas en pacientes con Trastorno Obsesivo Compulsivo // Efficacy...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
OCDDrug
Countries
United Kingdom, Italy, Spain, ...
Sponsor
Laboratorios Servier S.L.
Condition
OCD
Other study type icon
CompletedNCT02212041

Electronic Cigarettes in Smokers With Mental Illness

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
Schizophrenia, BipolarityOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.